Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study-Reference-Cited by-同舟云学术

Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study

Published:2020-08-17 Issue:1 Volume:72 Page:95-100
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Serranti Daniele,Nebbia Gabriella,Cananzi Mara,Nicastro Emanuele,Di Dato Fabiola,Nuti Federica,Garazzino Silvia,Silvestro Erika,Giacomet Vania,Forlanini Federica,Pinon Michele,Calvo Pier Luigi,Riva Silvia,Dodi Icilio,Cangelosi Antonina Marta,Antonucci Roberto,Ricci Silvia,Bartolini Elisa,Mastrangelo Greta,Trapani Sandra,Lenge Matteo,Gaio Paola,Vajro Pietro,Iorio Raffaele,D’Antiga Lorenzo,Indolfi Giuseppe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference21 articles.

1. Global prevalence of hepatitis C virus in children in 2018: a modelling study;Schmelzer;Lancet Gastroenterol Hepatol,2020

2. Direct-acting antivirals for children and adolescents with chronic hepatitis C;Indolfi;Lancet Child Adolesc Health,2018

3. The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection;Balistreri;Hepatology,2017

4. Direct-acting antiviral therapy is safe and effective in pediatric chronic hepatitis c: the public health perspective;Dhiman;J Pediatr Gastroenterol Nutr,2019

5. Treatment of chronic hepatitis c infection with direct acting antivirals in adolescents with thalassemia major;Nagral;Indian J Pediatr,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of Treatment With Sofosbuvir/Velpatasvir on Children’s Growth—Results of the PANDAA-PED Study;Pediatric Infectious Disease Journal;2024-09-04

2. Natural History and Management of Hepatitis C in Children: 25 Years Experience of a Reference Center in Northern Italy;Pediatric Infectious Disease Journal;2024-05-23

3. Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta‐analysis;Liver International;2024-01-31

4. Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the PANDAA‐PED study;Liver International;2023-06-08

5. Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study;Journal of Gastroenterology;2023-02-15